Ertapenem's Effects on Blood Glucose and Insulin Requirements

Clinical Evidence and Management

• The American Diabetes Association, as reported in Diabetes Care, suggests that infection-related hyperglycemia and increased insulin requirements are common in patients with infections, and these effects are not directly caused by ertapenem 1
• The American Diabetes Association, as reported in Diabetes Care, recommends monitoring blood glucose as dictated by the underlying infection and diabetes severity, and adjusting insulin based on infection-related stress hyperglycemia using standard protocols 1
• The American Diabetes Association, as reported in Diabetes Care, notes that insulin requirements may decrease as infection resolves with successful antimicrobial therapy, and that glucose changes should not be attributed to ertapenem itself, but rather to other causes such as infection severity, concurrent medications, or nutritional status 1
• The clinical approach to managing diabetes in patients receiving ertapenem should involve continuing standard diabetes management unchanged, with consideration of the potential for infection-related stress hyperglycemia and the need for adjusted insulin dosing 1, 2

Blood Sugar Management with Ertapenem Antibiotic

Monitoring and Management

• The American Diabetes Association recommends maintaining target blood glucose <180 mg/dL (10 mmol/L) in hospitalized patients to decrease risk of death, infection, and duration of stay, and checking capillary blood glucose before each meal and at bedtime (minimum every 6 hours) during active infection 3, 4
• Basal-bolus insulin regimens (e.g., glargine plus aspart) are preferred over sliding-scale insulin alone for superior glycemic control in hospitalized patients, with expected increased insulin requirements during active infection and decreased insulin needs as infection resolves 5, 6

Special Considerations

• In patients with chronic kidney disease (CKD) stages 4-5 (eGFR <30 mL/min/1.73 m²), insulin doses should be reduced by 25-50% prophylactically due to impaired renal insulin clearance, and ertapenem requires dose adjustment to 500 mg daily 7
• Prolonged fasting or irregular food intake in the perioperative/hospitalized setting creates hypoglycemia risk that compounds any antibiotic-related effects, emphasizing the need for vigilant glucose monitoring 3, 4